AI model aims to predict liver metastasis after colon cancer surgery
NCT ID NCT07399236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is developing an artificial intelligence (AI) model to predict the risk of liver metastasis in colorectal cancer patients after curative surgery. Researchers will analyze CT scans, pathology slides, and clinical data from 1,500 patients across multiple hospitals. The goal is to create a tool that can identify high-risk patients for personalized follow-up and treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a tool that helps doctors identify which colorectal cancer patients are at high risk of liver spread, enabling closer monitoring or earlier treatment.
- What could go wrong
- This is an early-stage, retrospective study using existing data, not a clinical trial testing a treatment. The AI model may not work as well in real-world settings or different patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER LIVER METASTASES (CRLM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital
RECRUITINGWuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.